To access this element change to forms mode OFF
Grant Award View - GA65785
Extending the time window for Tenecteplase by Effective Reperfusion of...
GA ID:
GA65785
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
12-Nov-2019
Publish Date:
16-Dec-2019
Category:
Health and Medical Research
Grant Term:
1-Jan-2020 to 31-Dec-2024
Value (AUD):
$2,750,598.00
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 18/19 1.1 Health and Medical Research
Grant Program:
Clinical Trials and Cohort Studies
Grant Activity:
Extending the time window for Tenecteplase by Effective Reperfusion of peNumbrAL tissue in patients with Large Vessel Occlusion (ETERNAL)
Purpose:
We will use a Phase III trial to investigate if a next generation drug, tenecteplase, is more effective than the current standard of care at improving patient outcomes up to 24 hours of stroke onset. This trial is particularly important because it will extend the stroke treatment time window with thrombolysis from 4.5 hours to 24 hours, allowing more patients to be treated, particularly in regional areas where patients are often outside of the established time window for treatment.
GO ID:
GO Title:
Clinical Trials and Cohort Studies 2019 Grant Opportunity
Internal Reference ID:
GNT1182533
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
University of Melbourne
Recipient ABN:
84 002 705 224
Grant Recipient Location
Suburb:
Parkville
Town/City:
Parkville
Postcode:
3052
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
NSW, VIC, SA
Postcode:
Multiple
Country:
AUSTRALIA